Science Explorer Back to mapMap
Discussion
Researcher · Simcere Pharmaceutical (China) · China

Dongsheng Chen

Dongsheng Chen publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Surgery, on topics such as Cancer Immunotherapy and Biomarkers, Cancer Genomics and Diagnostics and Ferroptosis and cancer prognosis.

ORCID 0000-0002-2732-1328 OpenAlex
World rank
#2,683,560
of 7,710,434 ranked researchers
Rank in China
#420,877
of 978,568
Works
52
Citations
485
Citations per work
9.3
h-index
12
i10-index 13Top 48% in Oncology
Dongsheng Chen

What does Dongsheng Chen research?

Dongsheng Chen's work is mostly in Medicine (41%), Biochemistry, Genetics and Molecular Biology (18%), Immunology and Microbiology (5%).

Health Sciences: 21 works · 41.3% of their workMedicine: 21 works · 41.3% of their workOncology: 9 works · 17.2% of their workPulmonary and Respiratory Medicine: 7 works · 13.1% of their workSurgery: 6 works · 11.0% of their workEverything else: 19 works · 36.0% of their workLife Sciences: 12 works · 22.7% of their workBiochemistry, Genetics and Molecular Biology: 9 works · 17.9% of their workCancer Research: 5 works · 10.3% of their workMolecular Biology: 4 works · 7.6% of their workImmunology and Microbiology: 2 works · 4.8% of their workImmunology: 2 works · 4.8% of their workTHEIR WORKDongsheng Chen52works
Life Sciences23%Health Sciences41%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine2141.3%
  2. Everything else1936.0%
    1. Biochemistry, Genetics and Molecular Biology917.9%
    2. Immunology and Microbiology24.8%
  1. 1Oncology17% of their works
  2. 2Pulmonary and Respiratory Medicine13% of their works
  3. 3Surgery11% of their works
  4. 4Cancer Research10% of their works
  5. 5Molecular Biology8% of their works
  6. 6Immunology5% of their works

Research topics

Which keywords describe Dongsheng Chen's research?

The keywords of their largest research topics: Tumor Microenvironment, Targeted Therapy, Immune Checkpoint Blockade, PD-1 and PD-L1, Cancer, Cancer Genomics, Mutational Signatures and Cell Death.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Tumor Microenvironment192 topics
  2. Targeted Therapy152 topics
  3. Immune Checkpoint Blockade131 topic
  4. PD-1 and PD-L1131 topic
  5. Cancer102 topics
  6. Cancer Genomics101 topic
  7. Mutational Signatures101 topic
  8. Cell Death61 topic
  9. Ferroptosis61 topic
  10. ALK Inhibitors51 topic
  11. Chemotherapy51 topic
  12. Color Psychology51 topic
  13. EGFR Mutations51 topic
  14. Gastric Cancer51 topic
  15. Kansei Engineering51 topic
  16. Dendritic Cells41 topic
  17. Immunity41 topic
  18. Long Noncoding RNAs41 topic
  19. RNA Regulation41 topic

Where does Dongsheng Chen work?

Dongsheng Chen's main affiliation in the publication record is Simcere Pharmaceutical (China), China.

How many publications and citations does Dongsheng Chen have?

OpenAlex counts 52 works and 485 citations for Dongsheng Chen, an h-index of 12, ranking #2,683,560 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Dongsheng Chen

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Dongsheng Chen. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.